Editorials Using monoamine oxidase type B inhibitors in Parkinson's disease BMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7466.581 (Published 09 September 2004) Cite this as: BMJ 2004;329:581 Article Related content Metrics Responses Peer review Data supplement Figure (pdf) Files in this Data Supplement: Figure Related articles Editor's Choice Parkinson's disease: a journey Published: 09 September 2004; BMJ 329 doi:10.1136/bmj.329.7466.0-h Paper Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients Published: 09 September 2004; BMJ 329 doi:10.1136/bmj.38184.606169.AE PAPERS Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients Published: 13 August 2004; BMJ doi:10.1136/bmj.38184.606169.AE See more Devolved powers for Greater Manchester led to some health improvements, study shows BMJ March 28, 2024, 384 q767; DOI: https://doi.org/10.1136/bmj.q767 Long waits in child mental health are a “ticking time bomb” regulator warns BMJ March 22, 2024, 384 q724; DOI: https://doi.org/10.1136/bmj.q724 Doctors report big rise in patients with illness because of socioeconomic factors BMJ March 01, 2024, 384 q538; DOI: https://doi.org/10.1136/bmj.q538 Diphtheria: WHO publishes first ever guidance following outbreaks BMJ February 14, 2024, 384 q407; DOI: https://doi.org/10.1136/bmj.q407 Measles outbreaks: Investing in patient relationships through GP continuity will be key to boosting MMR confidence BMJ January 29, 2024, 384 q221; DOI: https://doi.org/10.1136/bmj.q221 Cited by... Carphology by RajendraAbstract PDF